Cavosonstat is an orally bioavailable inhibitor of S-nitrosoglutathione reductase. Cavosonstat promotes cystic fibrosis transmembrane conductance regulator (CFTR) maturation and plasma membrane stability, with a mechanism of action complementary to CFTR correctors and potentiators.

1371587-51-7

C16H10ClNO3

299.71

N91115;N 91115;N-91115;Cavosonstat

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years